EXPRESSION THERAPEUTICS LLC has a total of 17 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology and pharmaceuticals are MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT, GILL PARKASH S and PREC BIOSCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Argentina | 1 | |
#6 | Brazil | 1 | |
#7 | Canada | 1 | |
#8 | China | 1 | |
#9 | Hong Kong | 1 | |
#10 | Japan | 1 | |
#11 | Republic of Korea | 1 | |
#12 | Mexico | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Denning Gabriela D C | 11 |
#2 | Gautney Richard E | 11 |
#3 | Lollar John S | 5 |
Publication | Filing date | Title |
---|---|---|
US2014011273A1 | High yield suspension cell line, system and method for making same | |
CN103764815A | Method and system for suspension cell culture | |
AU2002337901B2 | Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use |